Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Donovan

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Health & Place|January 5, 2023
Neighborhood greenspace and cognition: The cardiovascular health studySara L Godina, Andrea L Rosso, Jana A Hirsch, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
Dynamic contribution of nestin-expressing stem cells to adult neurogenesisDiane C Lagace, Mary C Whitman, Michele A Noonan, et al.
Critical Care Medicine|July 1, 1997
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator GroupS M Opal, C J Fisher, J F Dhainaut, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Health & Place|January 5, 2023
Neighborhood greenspace and cognition: The cardiovascular health studySara L Godina, Andrea L Rosso, Jana A Hirsch, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
Dynamic contribution of nestin-expressing stem cells to adult neurogenesisDiane C Lagace, Mary C Whitman, Michele A Noonan, et al.
Critical Care Medicine|July 1, 1997
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator GroupS M Opal, C J Fisher, J F Dhainaut, et al.
Pageof 11